Clinical Trials · NCT05762744
Pharmacogenomics of GLP1 Receptor Agonists
- Phase
- Phase 1
- Recruitment status
- Terminated
- Sponsor
- University of Maryland, Baltimore
- Enrollment
- 63
- Start date
- Jun 2016
- Locations
- 1 site, United States
- Primary endpoint
- Exenatide Effect on First Phase Insulin Secretion